Skip to main content
Download PDF
- Main
Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target.
- Cook, Peter;
- Thomas, Rozario;
- Kannan, Ram;
- de Leon, Esther;
- Drilon, Alexander;
- Rosenblum, Marc;
- Scaltriti, Maurizio;
- Benezra, Robert;
- Ventura, Andrea
Published Web Location
https://doi.org/10.1038/ncomms16187Abstract
This corrects the article DOI: 10.1038/ncomms15987.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.